Related Experiment Video
Updated: May 19, 2026

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes
Published on: February 24, 2017
Mir-24 regulates junctophilin-2 expression in cardiomyocytes.
Ming Xu1, Hao-Di Wu, Rong-Chang Li
1State Key Laboratory of Biomembrane and Membrane Biotechnology, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Third Hospital, College of Engineering and College of Life Sciences, Peking University, China.
MicroRNA-24 (miR-24) suppresses junctophilin-2 (JP2) expression, a key protein in heart cell function. This discovery reveals a new mechanism regulating excitation-contraction coupling and offers a potential therapeutic target for heart failure.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Gene Regulation
Background:
- Failing cardiomyocytes show impaired excitation-contraction (E-C) coupling.
- Downregulation of junctophilin-2 (JP2), crucial for E-C coupling, is a known mechanism.
- The regulation of JP2 expression was previously unknown.
Purpose of the Study:
- To investigate the role of microRNAs in regulating junctophilin-2 (JP2) expression.
- To identify specific microRNAs that target JP2 mRNA.
Main Methods:
- Bioinformatic analysis to predict microRNA binding sites on JP2 mRNA.
- Luciferase assays to confirm direct binding and functional effects.
- In vivo studies using an aortic stenosis model and adenovirus-mediated gene delivery.
Main Results:
- MicroRNA-24 (miR-24) was predicted to bind to JP2 mRNA's 3'-untranslated regions.
- Luciferase assays confirmed miR-24 directly suppresses JP2 expression.
- miR-24 was upregulated in failing cardiomyocytes; its overexpression reduced JP2 levels and impaired E-C coupling.
Conclusions:
- MiR-24 negatively regulates JP2 expression in cardiomyocytes.
- This miR-24-mediated suppression of JP2 is a novel mechanism for controlling E-C coupling.
- Targeting miR-24 may offer a new therapeutic strategy for heart failure.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Master Transcription Regulators
MAPK Signaling Cascades
